|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Revenue | |||
| Operating expenses: | |||
| Research and development | |||
| General and administrative | |||
| Total operating expenses | |||
| Operating loss | |||
| Other income: | |||
| Interest income | |||
| Bond accretion income | |||
| Gain on extinguishment of accounts payable | |||
| Interest expense | |||
| Debt discount amortization | |||
| Financing costs | |||
| Debt extinguishment costs | |||
| Total other income | |||
| Loss before provision for foreign income taxes | |||
| Net loss | |||
| Net loss per common share - basic | |||
| Net loss per common share - Diluted | |||
| Weighted Average Number of Shares Outstanding, Basic | |||
| Weighted Average Number of Shares Outstanding, Diluted | |||
| Other comprehensive loss: | |||
| Unrealized (loss) gain on available-for-sale securities | |||
| Comprehensive loss |
Loading...